Hong Kong Rainmed Medical Limited

RainMed Medical Group, founded in 2014, is a national high-tech enterprise committed to developing world's leading vascular interventional surgical robot. It focuses on the design, research and development, and commercialization of the robot digital function diagnosis module core products, including coronary angiography fractional flow reserve (caFFR) system, coronary angiography microvascular resistance index (caIMR) system, and FlashBot vascular interventional surgical robot. Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing and commercialization of medical instrument related to coronary angiography-derived